TFS Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-702
Closed -$37K 685
2016
Q4
$37K Buy
+702
New +$37K 0.01% 699
2016
Q2
Sell
-789
Closed -$45K 991
2016
Q1
$45K Buy
+789
New +$45K 0.01% 955
2015
Q4
Sell
-1,651
Closed -$261K 766
2015
Q3
$261K Buy
+1,651
New +$261K 0.03% 686